Charles River Laboratories



Ebitda változás Dátum
Agilent USD 484M 20M 2025-01
Align Technology USD 215.22M 15.06M 2024-12
Bio-Rad Laboratories USD 126.11M 19.25M 2024-12
Bruker USD 161.7M 29.3M 2024-12
Cardinal Health USD 758M 19M 2024-12
Charles River Laboratories USD 192.3M 43.95M 2024-12
Cigna USD 2.92B 386M 2024-12
CVS Health USD 3.58B 358M 2024-12
Danaher USD 2.02B 365M 2024-12
Dentsply International USD 126M 30M 2024-12
Galapagos EUR -48446000 52.4M 2024-09
Hologic USD 326.4M 15.5M 2024-12
Illumina USD 281M 48M 2024-12
Incyte USD 320.2M 128.19M 2024-12
IQVIA Holdings USD 925M 69M 2024-12
Laboratory Of America USD 401.3M 32.3M 2024-12
Lonza CHF 873M 107M 2024-06
McKesson USD 1.4B 162M 2024-12
Merck EUR 1.62B 114M 2024-09
Mettler Toledo International USD 365.41M 54.15M 2024-12
Novartis USD 5.19B 319M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Quest Diagnostics USD 513M 34M 2024-12
Revvity USD 216.63M 5.1M 2024-12
Thermo Fisher Scientific USD 2.99B 363M 2024-12
United Therapeutics USD 383.4M 43.9M 2024-12
UnitedHealth 9.73B 2.06B 2024-09
Walgreens Boots Alliance USD 794M 2.27B 2024-11
Waters USD 340.84M 80.08M 2024-12
West Pharmaceutical Services USD 208.6M 4.5M 2024-12



Charles River Laboratories - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.